BOSTON — Nov. 20, 2025 — Ginkgo Bioworks (NYSE: DNA) today announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to ...
Ginkgo Bioworks has announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build a standardized framework for ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する